Identification of Sestrin3 Involved in the In vitro Resistance of Colorectal Cancer Cells to Irinotecan.
Irinotecan, an analogue of camptothecin, is frequently used as a single agent or in combination with other anticancer drugs for the treatment of colorectal cancer. However, the drug resistance of tumors is a major obstacle to successful cancer treatment. In this study, we established that cells acqu...
Main Authors: | Seung Ho Choi, Hye Kyung Hong, Yong Beom Cho, Woo Yong Lee, Hae Yong Yoo |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2015-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4431826?pdf=render |
Similar Items
-
Prediction of novel target genes and pathways involved in irinotecan-resistant colorectal cancer.
by: Precious Takondwa Makondi, et al.
Published: (2017-01-01) -
Synergistic Effects of Simvastatin and Irinotecan against Colon Cancer Cells with or without Irinotecan Resistance
by: Hyun Joo Jang, et al.
Published: (2016-01-01) -
Association of CHFR Promoter Methylation with Treatment Outcomes of Irinotecan-Based Chemotherapy in Metastatic Colorectal Cancer
by: Yongjun Cha, et al.
Published: (2019-01-01) -
Explorating the Involvement of Plasma Sestrin2 in Obstructive Sleep Apnea
by: Rong Jiang, et al.
Published: (2019-01-01) -
Sestrin2 is involved in asthma: a case–control study
by: Yanfang Kang, et al.
Published: (2019-08-01)